Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer

Limited information on salvage treatment in patients affected by pancreatic cancer is available. At failure, about half of the patients present good performance status (PS) and are candidate for further treatment. Patients >18 years, PS ⩾50, with metastatic pancreatic adenocarcinoma previously tr...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Reni, M, Pasetto, L, Aprile, G, Cordio, S, Bonetto, E, Dell'oro, S, Passoni, P, Piemonti, L, Fugazza, C, Luppi, G, Milandri, C, Nicoletti, R, Zerbi, A, Balzano, G, Di Carlo, V, Brandes, A A
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Publishing Group 2006
Fag:	Clinical Study
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2361378/ https://ncbi.nlm.nih.gov/pubmed/16508631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603026
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer

Lignende værker